Corrigendum: Notoginsenoside R1 protects against diabetic cardiomyopathy through activating estrogen receptor α and its downstream signaling - Zhang, Bin; Zhang, Jingyi; Zhang, Chenyang; Zhang, Xuelian; Ye, Jingxue; Kuang, Shihuan; Sun, Guibo; Sun, Xiaobo (Frontiers in Pharmacology, 2025)